APA

Martin M., Ffumoleau M., Dewar J. A., Limentan A., Campone M. & Chang J. C.Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumad in patients with HER2-positive locally advanced or metastatic breast cancer: results from A phase IB. : .

Chicago

Martin M, Ffumoleau Martin, Dewar J A, Limentan Albanel, Campone M and Chang J C.Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumad in patients with HER2-positive locally advanced or metastatic breast cancer: results from A phase IB. : .

Harvard

Martin M., Ffumoleau M., Dewar J. A., Limentan A., Campone M. and Chang J. C.Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumad in patients with HER2-positive locally advanced or metastatic breast cancer: results from A phase IB. : .

MLA

Martin M, Ffumoleau Martin, Dewar J A, Limentan Albanel, Campone M and Chang J C.: . .